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1. Abstract 
 
Rationale 
The extracellular matrix (ECM) properties can be modified in multiple pathological 
processes either as a cause or as a result of the disease pathogenesis. In cancer, the loss of 
tissue homeostasis and mechanoreciprocity are considered one of the disease hallmarks. In 
particular, breast cancer has been defined as a disease of altered mechanobiology. It has 
been shown that an ECM gene signature can stratify breast cancer patients into subclasses 
that predict outcome. Increased breast tumor density in mammography has proven to be 
significantly correlated with reduced progression-free survival in metastatic patients. 
Studies on the tumor mechanobiology are thus expected to provide an insight into the 
disease pathogenesis as well as potentially useful biomarkers.  
Type I collagen is among the major determinants of breast ECM structural and tensile 
properties, and the collagen modifications during tumor evolution drive a number of 
disease-related processes that favor cancer progression and invasion. Here we have 
applied a porous type I collagen-based three-dimensional (3D) scaffold to study how 
breast cancer cells interact and alter extracellular collagen. Combining this culturing 
technique with different methodologies to characterize the structural and mechanical 
properties of collagen-based scaffolds we assessed the modifications induced by tumor 
cells on the micro- and macro- characteristic of extracellular collagen and on its 
compressive stiffness.  
 
Materials and methods  
The human breast cancer cell lines MCF7 and MDA-MB-231 were cultured for 10 days 
on porous collagen scaffolds. The two cell lines belong to breast tumor subtypes 
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characterized by different clinical aggressiveness and distinct in vivo ECM characteristics. 
MCF7 belong to the luminal A subtype and have a weak in vitro invasiveness, while 
MDA-MB-231 are basal-like breast cancer cells that are associated with a highly 
aggressive behavior. At the end of the culturing time, we characterized the cell 
morphological and molecular phenotypes and their drug sensitiveness. We next tested, the 
changes induced by cancer cells in the stiffness property of the scaffold, and in its 
structural micro- and macro- architecture. Mechanical testing was conducted both with an 
in-house built low-force compressive device and by Dynamic Mechanical Analysis. The 
stiffness of single collagen fibers was also assessed by Atomic Force Microscopy. We 
next used orthotopic xenotransplantion of the two cell lines to evaluate the collagen 
content and the degree of macroscopic collagen remodeling in in vivo breast tumors.   
 
Results  
When cultured on collagen scaffolds, the two cell lines generated coherent tissue-like 
structures. MCF7 displayed an epithelial morphology with a tightly cohesive cobblestone 
appearance and high levels of E-cadherin expression, while MDA-MB-231 showed a 
mesenchymal phenotype with lower cell-to-cell contact, a spindly appearance and high 
vimentin expression. MDA-MB-231, which belongs to the aggressive basal-like subtype, 
increased scaffold stiffness from 46.9 ± 2.7 kPa, to 57.9 ± 3.6 kPa, and overexpressed the 
matrix-modifying enzyme, lysyl oxidase (LOX), whereas luminal A MCF-7 cells did not 
significantly alter the mechanical characteristics of extracellular collagen. These data were 
obtained either using an in-house built mechanical testing device, and  a Dynamic 
Mechanical Analysis, a standard technique to measure the properties of biomaterials. 
The phenotype observed in vitro replicates the behavior of in vivo tumors generated by 
MDA-MB-231, characterized by higher collagen content and LOX levels than MCF-7. 
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When the activity of LOX was blocked, MDA-MB-231 were unable to increase the 
scaffold stiffness: scaffold compressive modulus increased by only 8.9%, in contrast to the 
increase observed without LOX inhibition (23%).  
No significant changes were observed between the Young’s modulus of fibers taken 
from control scaffolds, which was 1.08 ± 0.24 GPa, compared to the Young’s modulus of 
fibers taken from scaffolds decellularized after the culture with MDA-MB-231, which was 
1.1 GPa ± 0.05.  
 
Conclusions  
 Overall this work provides evidence that invasive, mesenchymal-like breast cancer 
cells produce high levels of the collagen crosslinking enzyme LOX, and are able to 
increase the stiffness of extracellular type I collagen and to alter its structural 
characteristics. Measurements of the compressive modulus of these soft synthetic 
extracellular matrices were carried out using a prototypal mechanical testing instrument 
originally designed and developed. A causal relationship between LOX expression and the 
ability of cancer cells to alter the stiffness of extracellular collagen was also provided. 
Our model offers a relevant in vitro tool to reproduce and investigate the biomechanical 
interplay subsisting between cancer cells and the surrounding ECM and its impact on the 
tumor phenotype and behavior.  
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2. Introduction 
 
2.1 Breast cancer 
Breast cancer is the most prevalent cancer diagnosed in women worldwide, and is the 
second leading cause of cancer death in women (Desantis et al., 2013 and Siegel et al., 
2016). It is now the most common cancer both in developed and developing regions. 
Breast cancer ranks as the fifth cause of death from cancer overall (Ferlay J et al., 2012). 
The majority of breast cancers diagnosed are ductal invasive carcinomas that arise from 
luminal or basal epithelial cells. Breast cancer can be classified into four categories based 
on microarray gene expression profile analysis: luminal A and luminal B subtypes, 
characterized by the expression of the Estrogen Receptor (ER) and the Progesteron 
Receptor (PGR); the HER2-positive subtype, characterized by the overexpression of the 
human epidermal growth factor receptor 2 (HER2); and the basal-like subtype (Basal A 
and Basal B) characterized by triple negativity for ER and PGR expression and for HER2 
overexpression (Sorlie et al., 2001). Expression of estrogen receptor (ER), progesterone 
receptor (PR), and HER2 receptor is used to determine the primary breast tumor subtype, 
the prognosis, and the targeted therapeutic regimen. Estrogen receptor (ER) and 
progesterone receptors (PR) are treated as predictive and prognostic markers (as per 
National Academy of Clinical Biochemistry guidelines). ER-α and PR should be measured 
in all patients with breast cancer and have clinical application. The presence of ER is an 
important discriminating factor: ER-positive tumors are associated with better prognosis, 
longer relapse-free survival, and improved overall survival compared to ER-negative 
tumors (Zhang et al., 2014 and Hoch et al., 1999). A number of targeted hormonal therapy 
are available for these patients. HER2-positive breast tumors show more aggressive 
features, but the treatment options have advanced through the use of monoclonal 
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antibodies to block HER2 activity (Dent et al., 2013). HER2 should be measured in all 
patients with invasive breast cancer. The primary purpose of measuring HER2 is to select 
patients with breast cancer that may be treated with trastuzumab.  
Ten to twenty percent of all invasive breast cancers diagnosed are classified as triple 
negative breast cancer (TNBC), a subtype characterized by lack of expression of ER or 
PR, and lack of HER2 overexpression. TNBCs typically are diagnosed at higher tumor 
stage and grade, show an aggressive biology and are associated with poor prognosis. 
Treatment options for TNBC patients are restricted to the use of cytotoxic chemotherapies, 
since these tumors do not respond to anti-hormonal therapy (Tomao et al., 2015). Even if 
TNBC patients usually respond to chemotherapy, they have shorter relapse-free survival 
(Carey et al., 2007 and Hudis et al. 2011). TNBC tumors are also more likely to develop 
resistance to chemotherapies and present with distant recurrence and visceral metastases 
(Carey et al., Hudis et al. and Anders et al.). Consequently, in order to advance the 
development of targeted therapeutics in TNBC, a better understanding of the underlying 
molecular mechanisms distinguishing TNBC from other breast cancer subtypes is critical. 
 
 
2.2 The extracellular matrix  
The extracellular matrix (ECM) is the non-cellular component of all tissues and organs, 
that provides essential physical scaffolding for the cells, and regulates crucial biochemical 
and mechanical cues that are required for tissue morphogenesis, differentiation and 
homeostasis. The importance of the ECM is clearly demonstrated by the wide range of 
diseases that arise from genetic abnormalities in ECM proteins (Jarvelainen H et al., 
2009). Essentially, the ECM is composed of two main classes of macromolecules: 
proteoglycans (PGs) and fibrous proteins. Each tissue has an ECM with a unique 
composition and topology that is generated during tissue development through a dynamic 
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interplay between the various cellular components (e.g. epithelial, fibroblast, adipocyte, 
endothelial elements) and the evolving cellular and protein microenvironment.  
Cell adhesion to the ECM is mediated by ECM receptors, such as integrins, discoidin 
domain receptors and syndecans (Frantz C et al., 2010). Adhesion mediates cytoskeletal 
coupling to the ECM and is involved in cell migration through the ECM (Schmidt S. and 
Friedl P., 2010). The ECM generates the biochemical and mechanical properties of each 
organ, such as its tensile and compressive strength and its elasticity. In addition, the ECM 
directs essential morphological organization and physiological function by binding growth 
factors (GFs) and interacting with cell-surface receptors to modulate signal transduction 
and gene transcription (Hynes RO, 2009).  
The ECM is a highly dynamic structure that is constantly being remodeled, either 
enzymatically or non-enzymatically, and its molecular components are subjected to a 
number of modifications. The physical, topological, and biochemical composition of the 
ECM is not only tissue-specific, but is also markedly heterogeneous (Frantz C et al., 
2010). ECM biochemical and mechanical properties in a given tissue can change from one 
physiological state to another. Also the composition and the architecture of the ECM, its 
interactions with the cellular constituents, and its post-translational modifications can vary 
extremely in a pathological conditions (for examples in aged tissue, wounded or fibrotic 
tissue and tumors). This ECM remodeling, in turn, cause functional consequences on 
cellular behaviors including altered GF sensitivity elicited by changes in ECM tension 
(Frantz C et al., 2010).  
 
 
2.3 The role of extracellular matrix in cancer  
The ECM has a vital role in the regulation of various biological pathways contributing to 
development, tissue homeostasis and diseases (Bonnans et al., 2014). ECM is involved in 
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a number of different biological process as the maintenance of tissue polarity, the 
induction or blockade of cell migration, the creation of molecule concentration 
gradients and the exertion of direct intracellular signals (Figure 1).  
 
 
 
 
Figure 1: schematic representation of the role of the ECM in different cellular 
processes (Pengfei et al., 2012). 
 
 
In particular, forces are essential for normal tissue-specific organization, in which they 
regulates cell survival, growth and migration, coordinating tissue development and 
function. 
ECM properties can be modified in multiple pathological processes either as a cause or as 
a result of the disease pathogenesis (Bonnans et al., 2014). Cancer is no longer merely 
considered as a disease of tumor cells: the imbalance of the tumor microenvironment also 
appears to play a crucial role. ECM, as the most abundant component in the tumor 
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microenvironment, can regulate cancer cell behavior and affect key tumor processes 
(Pengfei et al., 2012). Loss of tissue homeostasis and mechanoreciprocity are considered a 
hallmark of cancer.  
In particular, breast cancer has been defined as a disease of altered mechanobiology: 
matrix density, structure and stiffness, together with interstitial fluid pressure and flow, 
change during tumor evolution (Dvorak et al., 2011). As an example, the collagen matrix 
of breast cancer stroma is significantly stiffer and more linearized than in normal tissue, 
due to a progressive enzymatic crosslinking mediated by cancer cells. Linearized collagen 
fibers can, in turn, increase growth factor-dependent cell migration (Levental et al., 2009) 
Two primary mechanisms are involved in migration of cancer cells: the cell physical 
rearrangement linked to the epithelial to mesenchymal transition (EMT) (Mierke et al., 
2011 and Hoffman et al., 2011), and the reorientation of collagen by traction forces and by 
enzymatic cleavage (Wolf et al., 2007 and Gonzalez et al., 2010). Both can be regulated 
by tissue tension. Increased matrix cross-linking and ECM protein deposition or parallel 
reorientation of collagen can stiffen tissue locally and drive migration. Altered mechanical 
signaling can also affects cell survival, division and differentiation (Du Fort et al., 2011; 
Engler at al., 2006 and Janmey et al., 2011).
 
ECM remodeling is thus capable of affecting 
a number of tumor processes such as invasion, progression
 
(Levental et al., 2009), and 
metastasis initiation (Provenzano et al., 2006).  
 
 
2.4 Extracellular collagen and its modification 
Collagens comprise a large family of triple helical proteins and are the most abundant 
protein in human tissues, accounting for one-third of total proteins. There are now at least 
29 genetically distinct types of collagen identified, that are encoded by at least 44 genes 
that can be divided into several subgroups, depending on the molecular structure and 
13 
 
assembly mode (Hulmes, 2008). Fibril-forming collagens comprise the largest subgroup, 
including types I, II, III, V, XI, XXIV and XXVII. Fibrillar type I collagen is the most 
abundant type providing most tissues and organs with form, stability and connectivity. In 
addition to the structural functions, type I and other collagens also function as ligands for 
specific cell receptors, such as integrins, discoidin domain receptors, glycoprotein VI and 
the mannose receptor family etc., to control cellular activities and extracellular matrix 
remodeling (Leitinger, 2011). One of the most important factors for the structural and 
biomechanical functions of type I collagen fibrils are the post-translational modifications 
of peptidyl lysine residues. These modifications are highly regulated processes that can 
take place either inside or outside the cell. In the cell, the peptidyl lysine residues can be 
hydroxylated both in the helical and non-helical (telopeptide) domains of the molecule. 
Specific hydroxylysine residues in the helical domain can then be glycosylated with the 
addition of galactose, some of which can be further glycosylated with the addition of 
glucose. Specific enzymes catalyse each of these sequential and domain-specific lysine 
modifications. Outside the cell, an enzymatic oxidative deamination occurs to the 
telopeptidyl lysine and hydroxylysine residues, producing reactive aldehydic residues. The 
aldehydes then initiate a series of chemical condensation reactions to form extensive 
covalent intra- and inter-molecular cross-links, which are critical for the biomechanical 
functions of the collagen fibrils (Yamauchi, 2008).   
 
 
2.5 Collagen remodeling in breast cancer  
Increased deposition of collagens I, III and IV and enhanced collagen matrix cross-linking 
are among the ECM structural changes that occur during tumor progression (Zhu et al., 
1995; Lesniak et al., 2010 and Fang et al., 2014). Increased deposition and remodeling 
creates a reorganized microenvironment with significant impacts on tumor cell biology 
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including gene expression, cell differentiation, proliferation, migration and responses to 
treatments (Paszek et al., 2005). 
 
Breast cancer is a typical example of these changes. Collagen is the major component of 
the breast connective tissue and is a key determinant of its tensile properties
 
(Roeder et al., 
2002) and of the macroscopic deformability of mammary tumors
 
(Fenner et al., 2014) that 
are characterized by high collagen content and remodeling (Schedin et al., 2011).
 
Clinicians have long recognized the connection between breast density and breast cancer 
risk (Wolfe, 1976). Collagen surrounding normal epithelial structures in breast tissue is 
typically curly and smooth. However, parallel with tumor development, collagen 
progressively thickens, linearizes and stiffens fostering cell migration into ECM. Intravital 
imaging shows that breast cancer cells and leukocytes migrate rapidly along collagen 
fibers (Wyckoff et al., 2007). Cancer cells might exploit these remodeled stiff collagens as 
invasion "highways".  
 
 
2.6 The role of the matrix-modifying enzyme LOX   
Extracellular collagen remodeling is predominantly catalyzed by enzymes such as lysyl 
oxidase (LOX) (Xiao and Ge, 2012). There are five lysine or hydroxylysine residues in the 
telopeptide domains of type I collagen, two in the C-  and three in the N- telopeptide. 
These five lysine/hydroxylysine residues can be oxidatively deaminated by the copper 
(Cu2+)-dependent amine oxidase LOX to form the respective aldehydes which initiates a 
series of condensation reactions to form covalent intra- and inter-molecular cross-links 
(Figure 2) (Yamauchi and Sricholpech, 2012). 
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Figure 2. Lysine modifications in the telopeptide domains of type I collagen 
(Yamauchi and Sricholpech, 2012). 
 
 
LOX has been found to be synthesized in response to hypoxic conditions: hypoxia 
promote HIF-1–α mediated endogenous LOX gene expression. Subsequently, the collagen 
maturation occurs through the extracellular modification of collagen fibers by LOX, 
resulting in the formation of covalent cross-links (Makris et al., 2014) (Figure 3).  
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Figure 3. Mechanistic description of HIF-1–mediated LOX transcription and 
subsequent collagen cross-linking that enhance the biomechanical properties of 
collagen-rich tissues (Makris et al., 2014). 
 
 
 
In tumors, LOX can be synthesized by either stromal cells during early stages of 
carcinogenesis, or tumor cells during late stages of tumor progression. LOX, secreted by 
hypoxic tumor cells, crosslink collagens and elastin, thereby increasing insoluble matrix 
deposition and tissue stiffness (Erler et al., 2009).  
This enzyme have demonstrated a crucial role in breast cancer progression and metastatic 
spread. LOX is essential in driving tumor cells escape from primary site, extravasation and 
growth at secondary sites during metastasis (Erler et al., 2006 and Erler et al., 2009). It is 
reported that LOX can also be disseminated into distal target organs via circulation to 
create pre-metastatic niche both at lung (Erler et al., 2009) and bone sites (Cox et al., 
2015), as also evidenced by a consistent correlation between increased LOX expression 
and higher cancer metastasis risk (Erler et al., 2006). Finally, increased LOX expression is 
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associated with early stromal reaction in breast cancer, and reactive fibrosis at the invasive 
front of infiltrating tumors also releases high levels of LOX (Erler and Giaccia, 2006).  
 
 
2.7 Three-dimensional (3D) in vitro models to study cancer  
In vitro research offers several experimental methods and models to investigate the tumor 
mechanobiology (Carey et al., 2012). However, studies examining the relationship 
between ECM mechanics and cell phenotype have been hampered by limitations in the 
experimental approaches used to manipulate the biophysical properties of the ECM. The 
systems predominantly applied are mechanically tunable two-dimensional (2D) polymer 
hydrogels conjugated with ECM ligands (Tse et al., 2010; Young et al., 2011). These 2D 
substrates, unfortunately, fail to model the heterogeneous and three-dimensional (3D) 
structure of native tissue. For this reason, a number of innovative 3D systems have 
recently been developed and applied to investigate how cancer cells interact with the 
ECM, or to address the impact of mechanical signaling in diverse tumor phenotypes and 
behaviors in a  more physiological context (Cassereau et al., 2015; Paszek et al., 2005 and 
Wozniak et al., 2012). By employing 3D hydrogel substrates, Paszek and colleagues found 
that matrix compliance differs dramatically between 2D and 3D cultures, and between 
normal versus tumoral tissue in vivo. In this work the faithful recapitulation of tissue 
morphogenesis is favored by matrix conditions with an elastic modulus that corresponds 
with that of normal tissues in vivo. By examining the relationship between tissue rigidity 
and tumor behavior, Paszek and colleagues showed that tissue rigidity is linked to matrix 
stiffening and affects Rho GTPase-dependent cytoskeletal tension. They also found that 
matrix stiffness and cytoskeletal tension cooperate to modulate tissue behavior: matrix 
stiffness influences tissue growth and morphogenesis by modulating cell contractility, 
while tensional homeostasis appears to be necessary for normal tissue behavior. These 
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findings provided a new perspective on the role of the tissue microenvironment in 
tumorigenesis, providing new possible therapeutic targets (Paszek et al., 2005).  
However, the use of hydrogel still presents some limitations, including the failure to 
control the pore size, and the gel inconsistencies. On the other hand, synthetic polymer 
scaffolds allow for the fine-tuning of ECM mechanical properties, but fail to recapitulate 
the architecture and composition of a natural ECM, not enabling cells to interact and 
remodel the scaffold matrix (Miroshnikova et al., 2011; Miller et al., 2010). 3D 
biomimetic matrices represent the ideal systems to efficiently recapitulate tissue 
dimensionality and the biomechanical and physical cues of tumor ECM (Infanger et al., 
2013). Collagen-based scaffolds provide an efficient tool to mimic the ECM of soft tissues 
for in vitro research. These scaffold ideally show: i) high biocompatibility to allow cells to 
attach and proliferate; ii) a highly porous structure to allow cell and nutrient infiltration; 
iii) similar mechanical properties to the native tissue (Lamhamedi-Cherradi et al., 2014). 
Provenzano and colleagues, employed 3D collagen matrices that closely resemble the 
ECM architectures observed in vivo. They showed that utilizing in vivo-mimicking ECM 
conditions facilitates the acquisition of physiologically relevant information, while 
permitting manipulation of the system, and they used this matrix assays for studying 
contact guidance in vitro (Provenzano et al., 2010). Casserau and colleagues developed a 
novel tension bioreactor system that employs a native collagen I hydrogel and permits 
consistent manipulation of ECM stiffness in the absence of modifications to the structure, 
composition, or pore size of the gel. This system permitted precise mechanical tuning of 
collagen stiffness, while maintaining constant composition and pore size. Using this 
system Casserau and colleagues demonstrated that increasing ECM stiffness potentiates 
tumor cell migration, validating the use of this model to study malignant transformation 
and the invasive and migratory phenotype of tumor cells (Cassereau et al., 2015).  
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In conclusion natural and synthetic matrices can be used to recapitulate the interstitial 
ECM in in vitro culture with the aim to study tissue behavior or to deconstruct and analyze 
how specific ECM parameters (stiffness, fiber orientation, ligand presentation, 
dimensionality) provoke specific cellular behaviors (Figure 4). 
 
 
Figure 4. Schematic of the in vitro models presently used to generate 3D cancer 
cultures, with different methods and materials and control of physical and 
biochemical factors (Asghar et al., 2015). 
 
 
2.8 Cancer cell response to matrix stiffness in 3D models 
Matrix stiffness is an important parameter when studying the cellular response of cancer 
cells in 3D microenvironment (Chauhan VP et al., 2014). The matrix stiffness of different 
organs and tissues can be quantified by the Young's modulus (E) that can be soft as the 
brain tissue (ranging from 250 to 500 Pa) or rigid as the bone tissue (ranging from 1 to 25 
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GPa). The cellular response in microenvironments with different degrees of ECM 
mechanical stiffness is different. The matrix stiffness of solid tumors changes during the 
course of cancer metastasis and progression (Paszek et al., 2005). For instance, the 
microenvironment of breast tumor show a matrix with a high degree of stiffness (4000 Pa) 
compared to the healthy breast tissue (200 Pa) (Butcher et al., 2009) (Figure 5).  
 
 
 
Figure 5. Schematic representation of the stiffness properties of different human cells 
and tissues, and of the increasing stiffness observed in breast tumors (Butcher et al., 
2009). 
 
 
One of the most effective protein hydrogels that has been used to investigate cancer cell 
response to 3D matrices with different stiffness is collagen hydrogels, as previously 
described (Paszek et al., 2005). Stromal collagen deposition and crosslinking can define 
the stiffness of the tumor microenvironment and consequently can alter the cancer cell 
migration through the ECM (Carey et., 2012). In another report, a polyacrylamide 
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hydrogel substrate with varying stiffness was used to demonstrate that cells migrated from 
the soft substrate to the stiffer substrate (Levental et al., 2009). In another investigation, 
metastatic cancer cells were characterized by measuring the traction forces applied to 2D 
and 3D matrices by cancer cells on these substrates (Kraning-Rush et al., 2012). Breast, 
lung, and prostate cancer cells showed significantly stronger traction forces on the 
substrate at the late stage of the cancer disease compared to the normal healthy cells. 
Further, these results showed that cancer cells created stronger contractile forces on 
matrices with higher stiffness. The degrees of the traction and contraction forces generated 
by cancer cells are determined by the chemical and mechanical properties of the tumor 
microenvironment. 
 
 
2.9 Determination of the mechanical properties of soft tissue biomaterials  
The determination of mechanical properties of in vitro constructed ECM, as hydrogels or 
scaffolds, has becoming an important challenge for studying cell responses in these in 3D 
environments. Unlike hard tissue matrices, the mechanical properties of soft tissues can be 
challenging to be characterized. They usually can tolerate minimum stress, making it 
difficult to obtain precise measurement. Several experimental methods including three 
point bending, lateral and axial fiber vibration measurement, and direct axial tension tests 
have been exploited in recent years to characterize the mechanical properties of nanofibers 
(Edmondson et al, 2009). As an example, Florczyk and colleagues used dynamic 
mechanical compression to determine the stiffness of porous chytosan-hyaluronic acid 
matrices to recreate a scaffold with a Young’s modulus similar to that of the brain tissue 
and study human glioblastoma cells (Florczyk et al., 2013). 
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Other reported also the development of an in-house built instrument to measure the 
stiffness of small soft tissue samples. Fenner and colleagues developed a system to 
measure the nonlinear elastic behavior of soft tissues, using a cylindrical piston of known 
length and volume to indent tumor samples at steps of a known length (Figure 6), and 
recording changes in force for each successive step size that the cylindrical piston was 
applied to the specimen. The piston force, when knowing the degree of surface 
displacement, provided the nonlinear geometric stiffness characteristic for the given 
tumors. Using this system they were able to find an inverse correlation between the bulk 
modulus of freshly resected breast tumors generated by cancer cells xenotransplantation in 
murine models and the development of subsequent local recurrence and metastasis. In 
particular, the authors found that mice with compliant tumors were developing more 
frequent and larger local recurrences, and more extensive metastases than mice with 
relatively stiff tumors (Fenner et al., 2014).  
 
 
Figure 6. Photo of the piston compression device system used by Fenner and 
colleagues to measure the bulk moduli of ex vivo breast tumors (Fenner et al., 2014) 
 
 
Another recently developed solution is to determine matrices elastic modulus through 
nanoindentation (Zhu et al., 2011). Nanoindentation has been applied for characterizing 
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many soft materials' mechanical properties (Doube et al., 2010). In nanoindentation test, 
small loads can be used with an Atomic Force Microscope (AFM) (Barone et al., 2010). 
AFM can measure forces at the nN level (Clifford and Seah, 2006 and Darling et al., 2007) 
allowing measurement with a size-scale comparable to the cellular one, for a better 
understanding of the cell-substrate stiffness interaction. For example, Cavo and colleagues 
used AFM to measure the stiffness of an alginate hydrogel where breast cancer cells were 
cultured, demonstrating that stiffness directly influences cells fate (Cavo et al., 2016).  
Rheological testing has also been applied to study the mechanical properties of soft 
biological materials (Elango et al., 2016 and Yang et al., 2009). Although the storage 
moduli from rheological measurements is much different from tangent stiffness and, in 
rheological test, the movement of the interstitial fluid play a significant role in determining 
the overall mechanical properties of the samples (Xu et al., 2011).  
Combining the recently developed 3D culture systems with devices that can measure the 
mechanical characteristics of small tissue, gel or scaffold samples might shed new light on 
the relation between the stiffness properties of ECM and tumor cells and its influence on 
pathological cancer processes. The use of different techniques to measure the diverse 
mechanical properties that tissues exhibit under specific loading conditions can further 
improve our understanding on the cancer mechanobiology.  
 
 
2.10 Dynamic Mechanical Analysis  
Dynamic mechanical analysis (DMA) is a non-destructive technique widely used for the 
mechanical characterization of polymer-based systems, which is getting increasing 
importance in biomaterial research. Basically, it allows to characterize the viscoelastic 
properties of materials in a wide temperature and frequency ranges, by monitoring the 
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sample's response upon an imposed controlled cyclic load (with the corresponding 
development of stresses) or strain (Mano et al., 2002). The instrumentation of a DMA 
consists of a displacement sensor, such as a linear variable differential transformer 
(LVDT), a temperature control system or furnace, a force generator, a drive shaft support 
and guidance system to act as a guide for the force from the motor to the sample, and 
sample clamps in order to hold the sample being tested (Figure 7).  
 
 
Figure 7. Schematic of the main component of a dynamic mechanical analysis 
instrument. 
 
The samples is clamped into a frame and it is heated by the furnace. In the furnace the 
stress is applied from the force generator via a probe. The stress is applied as a sinusoidal 
force, to make the strain amplitude constant. The deformation of the sample is then 
detected. Mechanical properties such as elasticity or viscosity are derived from the stress 
applied and the strain, and plotted as a function of temperature or time. Several DMA 
equipments are now available, enabling studies in different mechanical configurations 
such as in tensile, flexural, compression or shear modes. Such studies are particularly 
relevant if the tests are performed at physiologically meaningful conditions, i.e., with the 
specimens completely incubated in solutions at 37 °C (Ghosh et al., 2008). 
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2.11 Atomic Force Microscopy  
In order to improve the applicability of soft biomaterials, as collagen scaffolds, a 
characterization of their structure and properties at a nanoscale level is required. This 
characterization can be performed by Atomic Force Microscopy (AFM) (Stylianou and 
Yova, 2013). AFM is a scanning probe microscope that records interactions between a 
probe and the sample surface. This technique has been introduced in 1980s, by Binnig and 
colleagues (Binnig et al., 1986), and has now become a fundamental method in surface 
and biomedical sciences.  
The AFM apparatus usually consists of a laser beam deflection system (optical lever) 
where a laser beam is reflected from the back of a cantilever (on which a very sharp tip is 
mounted to come into contact with a sample surface) and onto a position-sensitive detector 
(Stylianou A, 2017) (Figure 8).  
 
 
Figure 8. Schematic of an AFM apparatus consisting of a probe (cantilever and tip), 
a laser source, a scanner, a photodetector, the electronics, and a computer (Stylianou 
A, 2017). 
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The AFM gathers information with the probe, which is the tip mounted on the cantilever. 
The probe scans the sample surface and measures the atomic forces among probe sample 
surfaces. Τhe accurate movement of the tip over the surface of a sample under the tip, 
depending on the system, is achieved with piezoelectric elements. The measurement of the 
tip deflection is obtained via a laser beam and then transferred to the system’s electronics 
which form 3D images of the samples and/or assess other sample’s properties, such as 
stiffness, roughness or adhesion. The AFM can perform force spectroscopy of force 
volume for measuring mechanical properties of the samples: indentation-force curves are 
formed and fitted using mathematical expressions to calculate values that are needed for 
measuring the sample’s Young modulus and for creating material’s properties maps (e.g., 
Young’s modulus maps). Various theoretical and empirical models can be used to analyse 
force-displacement curves: the Hertz theory (Hertz, 1981; Kurland et al., 2012), the 
Johnson-Kindall-Roberts (JKR) model (Johnson et al., 1971) or the Derjaguin-Müller-
Toporov (DMT) model (Derjaguin et al., 1975). Recently, Bruker develop a new operating 
mode of AFM, called Peak Force Tapping. It provides high resolution images at a 
relatively high speed. When the tip is distant from the surface there is little or no force on 
the tip. As it approach the sample surface the cantilever is pulled down by attractive forces 
such as van der Waals, electrostatics or capillary forces. Then the tip touches the surface 
and stays on it until the Z position reaches its lowest position while the force is increasing. 
A constant force at this point is maintained by adjusting the extension of Z piezo through a 
feedback loop. After that the probe starts to withdraw and the force decreases until its 
minimum: at this point the surface forces of adhesion are determined. Finally, the tip 
leaves the surface and only long range forces affect it, and when the tip-sample separation 
is at its maximum there is a very small or zero force. Dependence of the force against the 
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Z-position can be compared with force-displacement curves that have usually been used in 
measuring mechanical properties of a sample. When the force curve is complete it is then 
analyzed to obtain the properties of the sample and the information is sent to one of the 
image data channel. Different material properties can be extracted, as elastic modulus, 
adhesion, energy dissipation and maximum deformation. The results are presented as maps 
of material properties in user-defined false colours (Kolářová et al., 2012).  
 
 
Figure 9. Schematic representation of the indentation steps (left), and of the 
mechanical informations (right) of the peak force tapping operating model of AFM 
(Kolářová et al., 2012).  
 
 
 
Compared to other techniques AFM has unique advantages, in particular over other 
microscopy techniques, such as Scanning or Transmission Electron Microscopy (SEM and 
TEM) and optical microscopy. First of all, AFM provides topological information at the 
nanoscale level that other microscopes cannot measure. Moreover, AFM can perform the 
characterization of the mechanical properties of samples at a nanoscale level, offering thus 
a combination of qualitative and quantitative information. Furthermore, AFM possesses 
the ability to perform nanoscale imaging/characterization without the need for presence of 
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vacuum conditions or any special treatment of the specimen, such as sample labeling or 
surface coating (Allison et al., 2010). AFM can be used for investigating a wide range of 
collagen-based structures, from collagen molecules to separated fibrils and fibers and 
collagen-based nanobiomaterials as well (Cisneros et al., 2007). The AFM characterization 
can be performed without destroying the fibrillar structure of collagen. As an example Zhu 
and colleagues successfully applied AFM nanoindentation in a liquid fashion to 
characterize the stiffness and the elastic modulus of collagen–chitosan hydrogel (Zhu et 
al., 2011).  
 
 
2.12 Translation impact  of these studies 
Investigations into breast tumor biomechanics provided a new insight into the disease 
pathogenesis, leading to the identification of clinically useful biomarkers. It has been 
shown that an ECM gene signature can stratify breast cancer patients into subclasses that 
predict outcome (Plodinec et al., 2012 and Bergamaschi et al., 2008). Bergamaschi and 
colleagues proved that primary breast tumors can be stratified upon ECM composition and 
that this classification provides relevant information on the biology of breast carcinomas, 
further supporting the hypothesis that clinical outcome is strongly related to stromal 
characteristics (Bergamaschi et al., 2008).  
Furthermore, molecular profile analyses carried out in other breast cancer cohorts as well 
as other tumor types, indicated that matrix molecules are present in expression signatures 
that classify disease progression (Perou et al., 2000; Sorlie et al., 2001; Van’t Veer and 
Weigelt, 2003; Sotiriou et al., 2003; Teschendorff  et al., 2007 and Mintz et al., 2005). 
Increased breast tumor density in mammography has proven to be significantly correlated 
with reduced progression-free survival in metastatic patients (Elsamany et al., 2014) and 
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to be an excellent predictor of response to tamoxifen in the preventive setting (Cuzick et 
al., 2011). With an observational study on breast cancer patients with metastatic disease, 
Elsamany and colleagues demonstrated that progression-free survival (PFS) was correlated 
with breast density. PFS, stratified by different prognostic factors, was assessed in low- 
compared to high-density patients. Among the enrolled patients, median PFS in low-
density patients was significantly better than those with high density. Breast density 
assessed at the time of diagnosis was significantly correlated with PFS of metastatic breast 
cancer patients, while survival outcome was improved in specific patients' subgroups with 
low breast density (Elsamany et al., 2014). 
Finally, Cuzick and colleagues conducted a nested case-control study within the first 
International Breast Cancer Intervention Study, a randomized prevention trial of tamoxifen 
vs. placebo. Mammographic breast density was assessed visually and expressed as a 
percentage of the total breast area in 5% increments. Case subjects were 123 women 
diagnosed with breast cancer at or after their first follow-up mammogram, which took 
place 12-18 months after trial entry. Control subjects were 942 women without breast 
cancer. In the tamoxifen arm, 46% of women had 10% or greater reduction in breast 
density at their 12- to 18-month mammogram. Compared with all women in the placebo 
group, women in the tamoxifen group who experienced 10% or greater reduction in breast 
density had 63% reduction in breast cancer risk, whereas those who took tamoxifen but 
experienced less than 10% reduction in breast density had no risk reduction. In the placebo 
arm, there was no statistically significant difference in breast cancer risk between subjects 
who experienced less than 10% reduction in mammographic density and subjects who 
experienced a greater reduction. The 12- to 18-month change in mammographic breast 
density thus emerged as an excellent predictor of response to tamoxifen in the preventive 
setting (Cuzick et al., 2011).  
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All these examples show how the study of the tumor mechanobiology can provide new 
possible disease biomarkers or therapeutic targets to help clinicians in the diagnosis, 
prognosis and treatment of breast cancer patients.  
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3. Aims 
 
In the present study we used an in vitro 3D cell culture model, based on porous type I 
collagen scaffolds, to investigate the ability of breast cancer cells to produce alterations in 
the structural and mechanical characteristics of extracellular collagen. This biomimetic 
matrix, providing a physiological 3D network, constitutes the model of choice to 
reproduce in vitro the cell-ECM interactions. We studied and applied different mechanical 
testing techniques and microscopy characterizations to assess the changes induced by 
cancer cells on the micro- and macro-structural properties of the collagen scaffolds, on the 
material median compressive stiffness and on the Young’s modulus of single collagen 
fibers.  
Specifically we:  
i. evaluated the phenotypes and behavior of two subtypes of breast cancer, 
characterized by different clinical aggressiveness, when cultured within the 
collagen scaffolds; 
ii. developed a prototype low-force instrument to measure the compressive properties 
of the collagen scaffolds; 
iii. evaluated the modifications induced by breast cancer cells on the compression-
dependent viscoelastic properties of the scaffolds; 
iv. evaluated the modifications induced by breast cancer cells on the micro properties 
of single collagen fibers; 
v. evaluated the modifications induced by breast cancer cells on the micro/macro- 
structures and protein composition of the scaffolds; 
vi. fabricated collagen scaffolds tuned to recreate distinct stiffness properties. 
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The overall aim was to demonstrate whether this 3D in vitro model might offer a valid and 
informative tool to recapitulate and investigate the biomechanical interaction that occurs 
between breast cancer cells and the surrounding ECM, focusing on the ability of invasive 
cancer cells to modify the structural and stiffness properties of extracellular collagen.  
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4. Materials and Methods 
 
4.1 Experimental in vitro model 
Two different human breast cancer cell lines, MCF-7 and MDA-MB-231, were cultured 
for 10 days on 3D porous collagen scaffolds. MCF-7 cells belong to the luminal A subtype 
of breast cancer (ER positive) and are associated with weak in vitro invasiveness, whereas 
MDA-MB-231 belong to the basal-like subtype (triple negative breast cancer TNBC) and 
are associated with an invasive behavior
 
(Holliday et al., 2011) and the ability to colonize 
different sites (e.g. bone, liver, lung and brain) after intravenous injection (Kang et al., 
2003). From the clinical standpoint the luminal A subtype is often connected to indolent 
disease and a better prognosis, while the basal-like subtype is connected to high-grade and 
aggressive disease. At the end of the culture time, the phenotypes of the two cell lines 
were characterized by morphological and molecular analyses.  
The scaffold samples were decellularized and their macro- and micro- mechanical and 
structural properties were tested to assess the modifications induced in the collagen matrix 
by either cell line (Liverani et al., 2017) (Figure 10). 
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Figure 10. Two human breast cancer cell lines, MCF-7 and MDA-MB-231, 
characterized by a diverse aggressive behavior, were cultured for 10 days on porous 
collagen-based 3D scaffolds. At the end of the culture time, cells were characterized 
for morphological and molecular phenotypes and the mechanical and structural 
properties of the scaffolds were analyzed (Liverani et al., 2017). 
 
 
4.2 Synthesis of the porous collagen scaffolds 
All chemicals were purchased from Sigma Aldrich (USA). The scaffolds were synthesized 
from type I bovine collagen as described elsewhere (Minardi et al., 2014). Briefly, a 1 
wt% collagen suspension in acetate buffer (pH 3.5) was prepared. The collagen was then 
precipitated at pH 5.5 with NaOH 1M. The collagen was then washed three times with 
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deionized water and then crosslinked in an aqueous solution of 1,4-butanediol diglycidyl 
ether (BDDGE) (2.5 mM), for 24 h. This cross-linking step is essential to determine the 
stiffness of the collagen matrix: higher concentrations of the crosslinking reagent 
(BDDGE) can generate scaffolds with increasing stiffness properties. Finally, the collagen 
was washed three times and casted in Teflon molds (9 mm in diameter) and freeze dried 
through an optimized freezing and heating ramp to obtain the desired pore size and 
porosity (from 25 °C to -25 °C and from -25°C to 25 °C in 50 min, p = 0.20 mbar). The 
morphology of the scaffold was characterized by scanning electron microscopy (SEM) and 
the pore size determined by ImageJ (US National Institutes of Health); the swelling 
properties of the scaffold and overall porosity were determined through water and ethanol 
infiltration methods (Minardi et al., 2014). Mean diameters were determined by caliper 
measurement. All analyses was performed both on control scaffolds and on scaffolds after 
a 10 days culture with MCF-7 and MDA-MB-231 (after a decellularization step).   
 
 
4.3 Cell seeding and culture 
MCF-7 and MDA-MB-231 cell lines were obtained from the American Type Culture 
Collection (USA). All cells were maintained in DMEM medium supplemented with 10% 
fetal bovine serum, 1% penicillin-streptomycin and 1% glutamine (PAA, USA) at 37°C in 
a 5% CO2 atmosphere. Each scaffold was placed in a 6-multiwell plate and seeded with 
5x10
12
 cells by dropping 50 µl of the cell suspension on the scaffold. Cells were allowed 
to adhere for 1 h at 37°C, after which 4 ml of culture medium were gently added to each 
well. After a 24-h incubation, all scaffolds were carefully removed and placed in a new 6-
multiwell plate. Medium was replaced daily. Uncellularized control scaffolds were 
maintained in cell-free culture medium at the same temperature and humidity conditions. 
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4.4 Cell quantification  
The number of cells that infiltrated the scaffold at day 10 was assessed by total DNA 
content quantification using the PicoGreen dsDNA assay (Invitrogen, Carlsbad, CA, 
USA). The total DNA was extracted using DNeasy Blood & Tissue Kit (Qiagen, 
Duesseldorf, Germany) following the manufacturer’s instructions and 100 µL of DNA 
mixture were then added to 100 µL of PicoGreen reagent working solution. Fluorescence 
of the samples was measured with a microplate reader (FLUOstar OPTIMA BMG 
LABTECH, Ortenberg, Germany) with excitation and emission wavelengths of 480 and 
520 nm, respectively. The total number of cells was determined using the conversion 
factor of 7.7 pg DNA/cell. 
 
 
4.5 Histological analysis 
The collagen constructs were fixed in 10% neutral buffered formaldehyde and dehydrated 
in a graded series of ethanol. Samples were then embedded in paraffin, sliced at a 
thickness of 5 µm with a rotating microtome (Leica Biosystems, USA) and mounted on 
Superfrost Plus microslides (Thermo Fisher Scientific, USA). Hematoxylin and eosin 
(H&E) staining was performed to evaluate cell morphology and distribution in the scaffold 
matrix. 
 
 
 
 
37 
 
4.6 LOX inhibition 
The activity of LOX was blocked by the irreversible LOX inhibitor, β-aminopropionitrile 
(BAPN) (Sigma Aldrich) (Nilsson et al., 2016; Yang et al., 2013 and Bondareva et al., 
2009). MDA-MB-231 within the scaffold were treated with 500 µM BAPN after 24 hours 
from the seeding. Administration of BAPN was performed daily until the end of the 
experiment. At day 10 the culture was stopped, cell proliferation in the presence or 
absence of LOX inhibition was assessed by MTT assay and the mechanical test was 
performed. 
 
 
4.7 Scaffold decellularization 
The scaffolds were decellularized in 0.5% Triton X-100 for 1 h at room temperature and 
then washed 3 times in phosphate saline buffer (PBS). Uncellularized scaffolds were 
exposed to the same decellularization process to ensure that the experimental conditions 
did not contribute to modify the scaffold’s mechanical properties. Decellularization was 
confirmed by the absence of MTT metabolism. The remaining DNA content of the 
decellularized scaffolds was assessed as follows: total DNA was extracted using the 
DNeasy Blood & Tissue Kit (Qiagen, Germany) following the manufacturer’s instructions 
and quantified with a NanoDrop ND-1000 spectrophotometer.  
 
 
4.8 Development of the low-force testing device  
We developed a prototype loading device to apply a state of unconfined uniaxial 
compression to the collagen scaffolds (Figure 11). This in-house built instrument 
consisted of a base support with a cylindrical hole (diameter 10 mm, depth 0.5 mm) 
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designed to lodge the scaffold specimen, and a cylindrical piston (diameter 10.1 mm) to 
indent the specimen with known force values. The applied stress (in kPa) could then be 
computed by dividing the applied force by the cross section of the specimen. The applied 
force consisted of a pre-load of 0.09 Newton (corresponding to a pre-stress of 1.8 kPa), 
which was held constant for 30 seconds; the full load of 0.38 Newton (corresponding to 
7.6 kPa) was then constantly applied for 30 seconds. Such holding times were sufficient 
for the visco-elastic time-dependent deformation to reach an equilibrium. The piston was 
equipped with a dial gauge (Borletti, Milan, Italy) to measure the piston displacement 
while the specimen was compressed. The consequent strain (dimensionless) was computed 
by dividing the measured piston displacement by the height of the specimen. The dial 
gauge had a resolution of 0.002 mm (corresponding to a resolution of 0.1% for the strain).  
 
 
Figure 11. Photo of the low-force mechanical testing device developed to measure the 
compressive modulus of the collagen scaffolds. 
 
 
39 
 
4.9 Mechanical testing 
4.9.1 Low-force testing device 
Prior to any measurements the scaffolds were decellularized in 0.5% Triton X-100 for 1 h 
at room temperature and then washed 3 times in phosphate saline buffer (PBS). 
Uncellularized scaffolds were exposed to the same decellularization process to ensure that 
the experimental conditions did not contribute to modify the scaffold’s mechanical 
properties. The specimens were tested in air immediately after having been removed from 
the PBS where they were soaked. For each sample, the pre-load of 0.09 Newton was 
constantly applied for 30 seconds, followed by the full load of 0.38 Newton, applied for 
other 30 seconds. The stiffness (compressive modulus, in kPa) of the collagen scaffold 
was computed as the ratio between the increment of stress and increment of strain from the 
pre-load to the full load values (Beer et al., 2011). The compressive modulus of collagen 
scaffolds decellularized after a 10-day culture with MCF-7 or MDA-MB-231 was 
compared with that of uncellularized scaffolds. Five specimens of each type were tested. 
Each specimen was tested 10 times to improve the quality of the measurement. The 
compressive modulus of each specimen was computed as the average of the 10 repeated 
measurements. 
 
4.9.2 Dynamic Mechanical Analysis (DMA) 
Compression tests were carried out also by dynamic mechanical analysis (DMA) using a 
Q800 instrument (Norleq, Portugal) (Figure 12), a standard methodology to characterize 
the mechanical properties of the scaffolds. As described before, prior to any measurements 
the scaffolds were decellularized in 0.5% Triton X-100 for 1 h at room temperature and 
then washed 3 times in phosphate saline buffer (PBS). Uncellularized scaffolds were 
exposed to the same decellularization process to ensure that the experimental conditions 
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did not contribute to modify the scaffold’s mechanical properties. Sample length and 
diameter were measured with a caliper before each testing.  The measurements were 
performed under compression mode, following cycles of constantly increasing loads, 
ranging from 0 to 0.01N. The test were carried out at room temperature. For each sample 
measurements were performed in 5 technical replicates for two biologically independent 
experiment.   
 
 
Figure 12. Photo of the Dynamic Mechanical Analysis instrument used to measure 
the compressive modulus of the collagen scaffolds. 
 
 
4.9.3 Atomic Force Microscpy (AFM) analysis 
The MultiModeNanoscope 8 (Bruker) atomic force microscope was used to perform the 
nanoindentation test (Figure 13). This instrument is an ultra-high resolution material 
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science microscope, equipped with ScanAsyst and PeakForce Quantitative 
Nanomechanical imaging modes and Peak Force Tapping technology. This microscope 
allowed for the determination of the mechanical characteristic of single collagen fibers. 
Fibers were removed from the bulky scaffold, suspended in MQ water and let dry on a 
mica surface. A sharp, rigid tip was used for probing the fiber mechanical properties. AFM 
images were collected using single-beam silicon cantilever probes (nominal tip radius of 
curvature 10 nm, force constant 0.65 N/m, tip half angle 18°C) from different samples and 
at random spot surface sampling (at least five areas per each sample). Quantitative 
mechanical characterization was determined under peak-force tapping mode with 1.0 Hz 
scan rates and a 200 mV amplitude set point. The DMT model (Derjaguin et al., 1975) was 
applied to calculate the Young's modulus. Several fibers were indented for each scaffold to 
calculate their strength.  
 
 
Figure 13. The Atomic Force Microscope used to measure the mechanical properties 
of single collagen fibers. 
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4.10 Microscopy analysis 
The collagen scaffolds were imaged by SEM and Laser Confocal Microscopy. For SEM 
imaging, samples were washed in 0.1 M sodium cacodylate buffer pH 7.4 and fixed in 
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.4 for 2 h at 4°C. Samples 
were then dehydrated in a graded series of ethanol, desiccated and sputter-coated with 
platinum. Images were acquired with a Nova NanoSEM (FEI, USA). For confocal 
imaging, cells were washed in 1% PBS, fixed with 4% paraformaldehyde for 20 min at 
room temperature and stained with 10 µM/ml DRAQ5 ™ (ImmunoChemistry 
Technology, Bloomington, MN, USA). Images where acquired with an A1 laser confocal 
microscope (Nikon Corporation, Tokyo, Japan), and analyzed with the NIS Elements 
software (Nikon Corporation, Tokyo, Japan). 
 
 
4.11 Quantitative Real-Time Reverse Transcription-PCR (qRT-PCR) 
Total mRNA was isolated using TRIzol Reagent (Invitrogen, USA) following the 
manufacturer’s instructions. Five hundred nanograms of RNA were reverse-transcribed 
using the iScript cDNA Synthesis Kit (BioRad, USA). The final mixture was incubated at 
25°C for 5 min, 42°C for 20 min, 47°C for 20 min, 50°C for 15 min and finally a 85°C for 
5 min. Real Time-PCR was performed in a 7500 Real-Time PCR System (Applied 
Biosystems, USA) using the TaqMan universal assay mix (Applied Biosystems). 
Amplification was performed in a final volume of 20 µl containing 2x Gene Expression 
Master Mix (Applied Biosystems) and 2 µl of cDNA. The reaction mixtures were all 
subjected to 2 min at 50°C, 10 min at 95°C followed by 40 PCR cycles at 95°C for 15 s 
and 60°C for 1 min. The stably expressed endogenous β-actin and HPRT were used as 
reference genes. Three target markers were analyzed: vimentin (VIM), E-cadherin 
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(CDH1) and lysyl oxidase (LOX). The amount of these transcripts was normalized to the 
endogenous reference genes and expressed as n-fold mRNA levels relative to a calibrator 
using the comparative threshold cycle (Ct) value method (ΔΔCt). For all analysis the 
calibrator used was a mix of the RNA extracted from MCF7 and MDA-MB-231 in 
standard monolayer culture.  
 
 
4.12 MTT assay 
Cell survival in MDA-MB-231 treated with the LOX inhibitor BAPN was assessed by 
MTT assay. Briefly, the scaffolds were incubated for 2 hours at 37°C in 0.5 mg/ml of 
MTT solution (Sigma Aldrich). After solubilization in acidic isopropanol, the absorbance 
was read at 550 nm. The cell survival was determined comparing the average absorbance 
of cells in the absence or presence of BAPN treatment.  
 
 
4.13 Drug testing 
Doxorubicin (DOXO) was administered in monolayer cultures or in the 3D scaffolds at the 
following concentrations: 0.8, 1.6 and 4 μg/ml. Cells were cultured for 24 h before 
exposure to the drug. Cell viability was assessed by MTT assay, as previously described. 
Survival percentages were calculated as the average absorbance of cells at each DOXO 
dose over the absorbance of untreated cells. 
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4.14 Xenograft study 
To establish orthotopic breast tumors, MCF-7-Luc2 and MDA-MB-231-Luc2 cells, both 
marked with a luciferase probe, were suspended in 100 µl of matrigel (BD, USA) at a 
concentration of 5 x 10
12
 cells and orthotopically injected into the right mammary fat pad 
of 8 week-old female immunodeficient nu/nu nude mice (n. 5 animals for each cell line). 
Tumor growth was followed by in vivo bioluminescence imaging and caliper measurement 
every 2-3 days after the injection. After 4 weeks, tumors were resected and embedded in 
Optimal Cutting Temperature (OCT) compound and cryo-sectioned. All experimental 
animal procedures were reviewed and approved by the Institutional Animal Care and Use 
Committee (IACUC) of the Houston Methodist Research Institute (HMRI) protocol 
number AUP 0614-0033. 
 
4.15 Collagen staining 
Trichrome staining and picrosirius red were performed on the OCT embedded frozen 
tissues to study the tumor collagen matrix and on the collagen scaffold sections. 
Trichrome staining (Abcam) was performed according to manufacturer’s instructions. For 
picrosirius red the frozen sections were stained with 0.1% (Direct Red 80) (Sigma 
Aldrich) sirius red in saturated aqueous solution of picric acid and counterstained with 
Weigert's hematoxilin. The RGB images were analyzed by ImageJ. At least n. 5 images 
per group were analyzed to quantify the collagen content.  
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4.16 Statistical analysis 
At least three independent experiments were performed. Data are presented as mean ± 
standard error (SE), with n indicating the number of replicates. For in vitro and in vivo 
data, differences between groups were assessed by a two-tailed Student's t-test and 
accepted as significant at p < 0.05.  
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5. Results 
5.1 Collagen remodeling in breast xenograft tumors 
Orthotopic implantation of MCF-7 and MDA-MB-231 in female immunodeficient mice 
was performed to investigate the collagen content and architecture in the ECM of in vivo 
breast tumors. After 4 weeks both cell lines had developed detectable mammary tumors. 
Bioluminescence imaging and caliper measurement showed that MCF-7 grew 
considerably slower than MDA-MB-231 displaying a mean tumor volume of 70 ± 15 µm
3
 
compared to 388 ± 68 µm
3
 for MDA-MB-231 (Figure 14a and 14b).  
                        a 
 
                        b 
 
Figure 14. Bioluminescence imaging (a) of mammary tumors in nude mice (n=5 for 
each group) generated by orthotopic injection of MCF-7 or MDA-MB-231 and 
caliper measurement (b) of tumor volume after 4 weeks (µm
3
). 
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Trichrome staining of resected tumor sections revealed a higher presence of thick collagen 
fibers in MDA-MB-231 orthotopic tumors compared to those generated by MCF-7 
(Figure 15a). Moreover, quantification of the collagen percentage in picrosirius red-
stained sections showed that MDA-MB-231 tumors displayed a significantly higher 
collagen content than that of MCF-7 ones (p = 0.0005) (Figure 15b). Finally, the in vivo 
expression of the matrix crosslinking enzyme LOX was markedly higher for MDA-MB-
231 than for MCF-7 (Figure 15c). 
 
 
       a 
 
 
Figure 15. (a) Trichrome staining of OCT-embedded xenograft breast tumors 
generated from orthotopic injection of MCF-7 and MDA-MB-231. 
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 b 
 
 
 
 
Figure 15. (b) Picrosirius red staining of OCT-embedded xenograft breast tumors 
generated from orthotopic injection of MCF-7 and MDA-MB-231, and quantification 
of the mean percentage of collagen to total area. 
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                     c 
 
Figure 15. (c) relative quantitation values of LOX in MCF-7 and MDA-MB-231 
orthotopic tumors. Data are mean ± SE. * p < 0.05. 
 
 
 
5.2 Collagen scaffold macro- and micro- structural properties 
Type I collagen scaffolds showed a mean diameter of 9 ± 0.5 mm (Figure 16a) and were 2 
mm thick. The pH-driven method, through which the collagen scaffolds were synthetized, 
enabled the production of a biomimetic material with highly reproducible morphology and 
tunable macro- and micro-structure, as characterized by Scanning Electron Microscopy 
(SEM). The size of the pores ranged between 150 to 300 μm, with a mean pore size of 197 
± 25 μm (Figures 16b and 16c). Collagen fibers showed a high degree of structural 
assembling and preserved their typical D-bands (arrowhead), (Figure 16d) a characteristic 
axial D-periodic (67 nm) morphology derived from the self-assembly of single collagen 
molecules. The scaffolds displayed a mean porosity percentage of 87.8 ± 4.1 (Table 1).  
The average pore volume was 25 x 10
3
 (±1300) μm3, the average pore diameter was 197 
(±25) μm and the pore walls were 15 (±1.0) μm thick (Table 1).  
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Figure 16. (a) Pictures of the collagen-based scaffold; (b-d) SEM analysis of the 
scaffolds at different magnifications with the typical D-bands (d) identified by white 
arrows and a yellow dotted line to show their axial disposition. 
 
 
Table 1.  
 
Physical properties of the collagen scaffolds. 
 
Average SD 
Scaffold Volume (µm
3
) 57.7 · 10
3
 ± 4.5 
Pore area (µm
2
) 24.7 · 10
3
 ± 1.3 
Volume of collagen (µm
3
) 8.8 10
3
 ± 0.5 
Void space (µm
3
) 48.9 10
3
 ± 0.2 
Porosity (%) 87.8 ± 4.1 
Average porosity diameter (µm) 197 25 
Pore wall thickness (µm) 14.7 ± 1.0 
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5.3 Phenotypes and behavior of breast cancer cells on the collagen matrix 
The porous structure of the collagen matrix allowed for cell penetration throughout the 
scaffold, as detected by the MTT assay at 10 days of culture. The MTT assay is a 
colorimetric assay for measuring cell metabolic activity, reflecting the number of present 
viable cells. Cellular oxidoreductase enzymes are capable of reducing the tetrazolium dye 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to insoluble 
formazan, which has a purple color. After 10 days of culture with MCF-7 or MDA-MB-
231, the scaffold, stained with the tetrazolium dye MTT, appeared homogeneously purple-
colored, indicating that cancer cells had penetrated throughout the material and populated 
all the scaffold regions. Conversely, the MTT dye was not reduced in empty control 
scaffolds (Figure 17).  
 
Figure 17. MTT assay of MCF-7 and MDA-MB-23 cultured on the 3D scaffold, 
compared to an empty control scaffold (ctrl). Scale bars: 3 mm. 
 
 
 
While MCF-7 are associated with weak invasiveness, MDA-MB-231 are enriched for 
epithelial to mesenchymal transition (EMT) markers and display a more invasive 
behavior. When cultured on collagen scaffolds, the two cell lines generated tissue-like 
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structures and maintained their distinctive features: MCF-7 displayed an epithelial-like 
morphology with a tightly cohesive cobblestone appearance, while MDA-MB-231 showed 
a mesenchymal phenotype with lower cell-to-cell contact and a spindle appearance 
(Figure 18a). Both cell lines proliferated within the scaffold, and at day 10 the number of 
cells reached about 9 x 10
6 
for MCF-7 and 9.8 x 10
6 
for MDA-MB-231 (Figure 18b). 
Gene expression analysis showed that MCF-7 had a high level of E-cadherin expression 
but low vimentin, while MDA-MB-231 showed lower levels of E-cadherin and a high 
vimentin expression (Figure 18c).  
 
a 
 
 
Figure 18. (a) Hematoxylin & eosin staining of paraffin-embedded sections of the 3D 
scaffolds cultured with MCF-7 or MDA-MB-231, and SEM imaging of scaffolds 
cultured with MCF-7 or MDA-MB-231. 
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              b 
 
Figure 18. (b) number of MCF-7 and MDA-MB-231 that infiltrated the collagen 
scaffold at day 10 of culture. 
 
 
 
 
          c 
 
Figure 18. (c) Relative quantitation values of E-cadherin (CDH1) and vimentin 
(VIM) in MCF-7 and MDA-MB-231 cells. 
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Confocal microscopy analysis of cellularized scaffolds showed MCF-7 aggregated in 
clusters with epithelial-like morphology and higher cell-cell contact (Figure 19a). 
Conversely, MDA-MB-231 cells displayed a spindle shaped mesenchymal phenotypes, 
limited cell to cell contact and an aligned distribution (arrowhead) over the collagen 
fibrils, resembling a clinical feature of invasive lobular breast tumors known as “Indian 
filing” (Provenzano et al., 2006) (Figure 19b). DAPI-stained frozen sections of the 3D 
scaffold revealed that in MCF-7 the cell distribution over core and rim areas remained 
similar between day 1 and day 7 (Figure 19c). Conversely, this distribution was 
significantly different (P = 0.023 and P = 0.046 at day 1 and 7, respectively) for MDA-
MB-231 cells that radially concentrated at the rim of the scaffold over time (Figure 19d). 
This result, together with the Indian file distribution, suggested the activation of a 
collective migratory process toward the scaffold’s edges. 
 
a                              MCF-7 
 
Figure 19. (a) Confocal microscopy images at different magnifications of MCF-7 
within the scaffold (3D) at day 7. Cells are stained with DRAQ5 (red) and blue is the 
collagen scaffold autofluorescence. 
 
 
55 
 
 
 
 
b                              MDA-MB-231 
 
Figure 19. (b) Confocal microscopy images at different magnifications of MDA-MB-
231 within the scaffold (3D) at day 7. Cells are stained with DRAQ5 (red) and blue is 
the collagen scaffold autofluorescence. 
 
 
 
 
c 
 
 
Figure 19. (c) Whole images of histological sections of 3D cultured MCF-7 at day 1 
and 7, and percentages of cells in edge or core regions of the scaffold. Cells are 
stained with DAPI (yellow) and red is the collagen scaffold autofluorescence. Data 
represent mean ± S.D. (n = 3) *p < 0.05, two-tailed Student's t-test. 
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d 
 
 
Figure 19. (d) Whole images of histological sections of 3D cultured MDA-MB-231 at 
day 1 and 7, and percentages of cells in edge or core regions of the scaffold. Cells are 
stained with DAPI (yellow) and red is the collagen scaffold autofluorescence. Data 
represent mean ± S.D. (n = 3) *p < 0.05, two-tailed Student's t-test. 
 
 
 
 
MDA-MB-231 proved capable of internalizing collagen: confocal images of the scaffold 
matrix showed the presence of blue collagen spots in the scaffolds cellularized with MDA-
MB-231. These signals were not detectable in empty scaffolds or in the presence of MCF-
7 cells (Figure 20a).  The collagen spots demonstrated an intracellular localization that 
was further highlighted in images processed with ImageJ software (Figure 20b).  
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a 
 
Figure 20. (a) Confocal images of the collagen matrix (blue, autofluorescence) of an 
empty scaffold (uncell), and of scaffolds cellularized with MCF-7 or with MDA-MB-
231 
 
                b 
 
Figure 20. (b) Confocal microscopy analysis of GFP-labeled MDA-MB-231 (green, 
GFP) on collagen scaffolds (blue, autofluorescence) and processed images to exclude 
the cell signal. 
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Finally, culturing within the scaffold model affected the sensitiveness of cancer cells to 
Doxorubicin (DOXO): both cell lines showed a decreased sensitivity to DOXO compared 
to that of monolayer cultures, as proven by the higher survival rates observed in all tested 
concentrations (Figure 21). MCF-7 within the 3D model proved to be completely resistant 
to DOXO at the highest tested concentration (4 µg/ml). 
 
MCF-7 
 
 
MDA-MB-231 
 
 
Figure 21. Percentages of survival of MCF-7 and MDA-MB-231 after 3 days of 
DOXO treatment at different concentrations in monolayer culture (2D) or within the 
scaffold (3D).  
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5.4 Assessment of the low-force testing device repeatability 
Preliminary tests were performed on scaffolds cultured with MDA-MB-231 to evaluate the 
repeatability of the measures obtained with the prototype loading device. The instrument 
and setting conditions exhibited good consistency that resulted in homogeneous dispersion 
of the different measures, as well as of the average values of technical replicates (Figure 
22). The intra-assay coefficient of variation was 10.7 %, which was deemed sufficient for 
our purposes. No conditioning effect was detected when the same specimen was 
repeatedly loaded, as it can be observed in Table 2a and b.  
 
 
MDA-MB-231 
 
 
Figure 22. Stiffness values for uncellularized (uncell) scaffolds or for scaffolds 
decellularized (decell) after a 10-day culture with MDA-MB-231, expressed as the 
slope of the sigma-epsilon curve (sigma-eps) (kPa).  
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Table 2a 
 
 
Table 2b 
 
 
The raw data of stress-strain of an empty scaffold (Table 2a) and a scaffold with 
MDA-MB-231 (Table 2b) (for each scaffold ten repeated measurements have been 
performed). As it can be noted, no pre-conditioning effect was observed and the data 
showed good reproducibility. 
 
 
5.5 Alteration of the compressive stiffness of collagen scaffolds by invasive breast 
cancer cells 
We investigated the effect of MCF-7 and MDA-MB-231 on the stiffness properties of 
collagen scaffolds by comparing the compressive modulus of uncellularized samples with 
that of samples decellularized after 10 days of culture with either cell line. The efficacy of 
the decellularization process was confirmed by MTT metabolization, which resulted 
almost absent in decellularized samples (Figure 23a). Furthermore, the residual DNA 
content in decellularized scaffolds resulted of 11.1 ± 4.9 ng/µl compared to 175.9 ± 16.46 
ng/µl of cellularized ones (Figure 23b).  
 
 
 
Stress 
(kPa) 
Strain (adimens) 
mean SE 
4.56 0.111 0.125 0.139 0.109 0.101 0.121 0.117 0.105 0.120 0.111 0.116 0.013 
Stress 
(kPa) 
Strain (adimens) 
mean SE 
4.56 0.098 0.096 0.107 0.090 0.098 0.093 0.090 0.082 0.110 0.106 0.098 0.009 
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      a                                                          b 
 
Figure 23. (a) 550 nm absorbance of uncellularized, cellularized (cell) or 
decellularized MTT-stained scaffolds; (b) DNA content (ng/µl) of uncellularized, 
cellularized or decellularized scaffolds. 
 
 
MCF-7 did not significantly affect the mechanical properties of the scaffolds: 
uncellularized samples displayed an average compressive modulus of 47.1 ± 1.8 kPa, 
while samples decellularized after MCF-7 culture showed an average compressive 
modulus of 48.9 ± 1.3 kPa. Conversely, MDA-MB-231 cells produced a significant (p= 
0.038) increase in the scaffold stiffness: uncellularized samples displayed an average 
compressive modulus of 46.9 ± 2.7 kPa, while samples decellularized after MDA-MB-231 
culture had an average compressive modulus of 57.9 ± 3.6 kPa (Figure 24a). Scaffold 
compressive modulus increased by 23% after MDA-MB-231 cell culture, in sharp contrast 
to the increase observed after culture with MCF-7 which was lower than 5% (Figure 24b). 
Finally, MDA-MB-231 within the collagen scaffolds showed around a 1000-fold higher 
expression level of LOX than MCF-7 (Figure 24c). 
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    a    
 
Figure 24. (a) Average slope of the sigma-eps curve (kPa) for uncellularized scaffolds 
or for scaffolds decellularized after a 10-day culture with MCF-7 or with MDA-MB-
231. Data are mean ± SE. * p < 0.05. 
 
 
 
 
  
Figure 24. (b) Percentage increase in the slope of the sigma-eps curve for scaffolds 
decellularized after a 10-day culture with MCF-7 or MDA-MB-231 with respect to 
uncellularized scaffolds. Data are mean ± SE.  
63 
 
  
Figure 24. (c) Relative quantitation values of LOX in MCF-7 and MDA-MB231. Data 
are mean ± SE. * p < 0.05. 
 
 
5.6 Dynamic Mechanical Analysis of collagen scaffolds 
Mechanical testing in compression was performed also by DMA, comparing 
uncellularized control scaffolds with scaffolds decellularized after 10 days of culture with 
MDA-MB-231. Under compression all scaffolds exhibited the typical behavior of 
elastomers. Three characteristic deformation stages were identified: a linear elastic stage, 
followed by a stress plateau and, finally, a densification stage, characterized by a strong 
increase in the slope of the stress-strain curves. Representative compression stress-strain 
curves of controls scaffold and scaffolds cultured with MDA-MB-231 are reported in 
Figure 25a and b.  
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                 a                        ctrl 
 
Figure 25. (a) Unidirectional compression stress (MPa) strain (%) curves of 
uncellularized collagen scaffolds.  
 
 
 
 
              b                   MDA-MB-231 
 
 
 
Figure 25. (b) Unidirectional compression stress (MPa) strain (%) curves of collagen 
scaffolds after a 10-day culture with MDA-MB-231. 
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The slope of the initial linear stage on the stress strain curves represents the compressive 
modulus of the scaffolds (Figure 26a and b).  
 
a                                   ctrl 
 
 
Figure 26. (a) Example of the initial linear stage of a compression stress (MPa) strain 
curve of uncellularized collagen scaffolds.  
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b                              MDA-MB-231 
 
Figure 26. (b) Example of the initial linear stage of a compression stress (MPa) strain 
curve of collagen scaffolds after a 10-day culture with MDA-MB-231. 
 
A 41% increase in the scaffold compressive modulus was observed after MDA-MB-231 
culture: control samples displayed an average modulus of 1.7 ± 0.7 kPa, vs. 2.4 ± 0.4 kPa 
in samples cultured with MDA-MB-231 (Figure 27). This difference is not statistically 
significant (p= 0.052). 
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Figure 27. Average compressive modulus (kPa) for uncellularized scaffolds (ctrl) or 
for scaffolds decellularized after a 10-day culture with MDA-MB-231. Data are mean 
± SE.  
 
 
These differences between control scaffolds and scaffolds in contact with MDA-MB-231 
were similar to that observed with the prototype low-force compressive device, although 
the absolute compressive modulus values determined by DMA analysis resulted markedly 
lower than that determined with the prototype device. The ability of MDA-MB-231 to 
induce an increase in the stiffness of the scaffold was confirmed.   
 
 
5.7 Collagen scaffold remodeling by breast cancer cells 
After 10 days of culture within the scaffold, MCF-7 and MDA-MB-231 altered the 
structural micro- and macro- characteristics of the collagen matrix. A significant decrease 
in the scaffold swelling property was produced by both cell lines with respect to 
uncellularized samples (p= 0.022 for MCF-7 and p= 0.042 for MDA-MB-231) (Figure 
28a). The average porosity was also reduced, although the data were not statistically 
significant (Figure 28b). Both cell lines decreased the mean pore area of the scaffold, but 
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the decrease produced by MDA-MB-231 was higher compared to that of MCF-7 (p= 
0.002 for MDA-MB-231) (Figure 28c).  
 
 
Figure 28. (a) Swelling property of the collagen scaffolds comparing samples without 
cells (uncell) and samples decellularized after a 10-day culture with MCF-7 or with 
MDA-MB-231. 
 
 
Figure 28. (b) Average porosity (%) of the collagen scaffolds comparing samples 
without cells (uncell) and samples decellularized after a 10-day culture with MCF-7 
or with MDA-MB-231. 
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Figure 28. (c) Average pore area of the collagen scaffolds comparing samples without 
cells (uncell) and samples decellularized after a 10-day culture with MCF-7 or with 
MDA-MB-231. 
 
 
SEM analysis showed the presence of a rough and irregular matrix over the scaffold 
surface detected after MCF-7 and MDA-MB-231 culture, while uncellularized samples 
displayed a smooth and regular surface (Figure 29).  
Collagen quantification by picrosirius red staining showed that the two cell lines did not 
increase the collagen content of the scaffold. On the contrary, collagen percentage area 
resulted significantly lower in scaffolds cultured with MCF-7 than in uncellularized 
samples (Figure 30). This result suggests that also matrix proteins other than collagen 
were deposited by the two cell lines.   
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               Uncell                      MCF-7                MDA-MB-231 
 
 
Figure 29. SEM analysis at different magnifications of the scaffolds without cells 
(uncell) and decellularized after a 10-day culture with MCF-7 or with MDA-MB-231. 
Of note: the decellularization process was performed also on empty scaffolds in order 
to avoid any contribution of this process on the difference between samples without 
cells and samples decellularized after culture with MCF-7 or MDA-MB-231; the 
decellularization process affected the scaffold structure, as detected at SEM analysis. 
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               Uncell                      MCF-7                MDA-MB-231 
 
 
Figure 30. Picrosirius red staining of paraffin-embedded scaffolds without cells 
(uncell) and scaffolds decellularized after a 10-day culture with MCF-7 or with 
MDA-MB-231, with quantification of the mean percentage of collagen to total area. 
Data are mean ± SE. * p < 0.05.  
 
 
The matrix architecture in the scaffold was markedly different between sample 
uncellularized and sample cultured with MCF-7 or MDA-MB-231 as detected by 
Masson’s thricrome staining. In particular, the matrix appeared more organized, highly 
packed and with linear collagen fibers (arrowhead) in the presence of MDA-MB-231. 
While uncellularized scaffolds and scaffolds cultured with MCF-7 display a more 
dispersed and disorganized matrix (Figure 31).  
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                  Uncell                         MCF-7                 MDA-MB-231 
 
Figure 31. Trichrome staining of paraffin-embedded scaffolds without cells (uncell) 
and decellularized after a 10-day culture with MCF-7 or with MDA-MB-231. 
 
 
 
5.8 LOX inhibition impairs MDA-MB-231 ability to increase collagen stiffness  
Treatment with BAPN did not affect proliferation of MDA-MB-231, as the survival 
percentage of treated cells was similar to that of untreated controls (Figure 32a). In the 
presence of LOX inhibition the ability of MDA-MB-231 to increase the stiffness of the 
collagen scaffold was reduced: uncellularized samples displayed an average compressive 
modulus of 55.5 ± 2.6 kPa, while samples decellularized after MDA-MB-231 culture with 
BAPN treatment showed an average compressive modulus of 58.1 ± 5.2 kPa (Figure 
32b). Scaffold compressive modulus increased by 8.9%, in contrast to the increase 
observed without LOX inhibition (23%) (Figure 32c). 
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                 a    
 
Figure 32. (a) Survival percentages of MDA-MB-231 cultured within the scaffold in 
the absence (NO BAPN) or presence (BAPN) of a LOX inhibitor. Data are mean ± 
SE. 
 
 
 
                                b    
 
Figure 32. (b) Average slope of the sigma-eps curve (kPa) for uncellularized scaffolds 
or for scaffolds decellularized after a 10-day culture with MDA-MB-231 in the 
presence of LOX inhibition. Data are mean ± SE. 
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              c    
 
Figure 32. (c) Percentage increase in the slope of the sigma-eps curve for scaffolds 
decellularized after a 10-day culture with MDA-MB-231 in the presence or absence 
of LOX inhibition (BAPN and NO BAPN, respectively) with respect to uncellularized 
scaffolds. Data are mean ± SE.  
 
 
 
5.9 Atomic Force Microscopy analysis of single collagen fibers 
We used a surface mapping technique called PeakForce QNM AFM in order to evaluate 
the nanomechanical features of the fibers of uncellularized control scaffolds and scaffolds 
after a 10 day culture with MDA-MB-231. AFM images of the collagen fibers were 
collected from different samples and at random spot surface sampling (Figure 33a and b).  
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a                               ctrl 
 
 
Figure 33. (a) Representative images of a collagen fiber taken from an uncellularized 
scaffold at the Atomic Force Microscope. 
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a                           MDA-MB-231 
 
Figure 33. (b) Representative images of a collagen fiber taken from a scaffold 
decellularized after a 10-day culture with MDA-MB-231 at the Atomic Force 
Microscope. 
 
 
No significant differences were observed between the Young’s modulus of fibers taken 
from control scaffolds, which was 1.08 ± 0.24 GPa, compared to the Young’s modulus of 
fibers taken from scaffolds decellularized after the culture with MDA-MB-231, which was 
1.1 GPa ± 0.05  (Figure 34). This results could be explained by the functional correlation 
found between the ability of MDA-MB-231 to increase the scaffold’s stiffness and the 
activity of LOX. The collagen cross-linking mediated by this enzyme involve inter-fibers 
bonds that are probably lost with this type of analysis that allow for the determination of 
the strength of single fibers.    
77 
 
 
Figure 34. Young's modulus of fibers taken from uncellularized scaffolds (ctrl) 
compared to fibers taken from scaffolds decellularized after the culture with MDA-
MB-231. 
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6. Discussion  
Physical sciences and engineering have introduced novel perspectives into the study of 
cancer through model systems, tools, and metrics that enable a higher integration of basic 
science observations with clinical data (Cassereau et al., 2015; Paszek et al., 2005 and 
Wozniak et al., 2012 ). Empirical studies that employ complex in vitro and in vivo model 
systems to assess and control cell behavior and/or mathematical models that simulate 
molecular and cellular processes (Carey SP et al., 2012) have contributed to the 
identification of several complex mechanisms that drive processes during cancer 
progression including tumor growth, angiogenesis, and metastasis. In particular, the use of 
three-dimensional culturing models has recently open the window to a new era for cancer 
research. The generation of 3D cancer models with various technologies (i.e. the use of 
spheroids, bio-printing, or assembly) has allowed to recapitulate and control defined 
physical and biochemical factors while culturing cancer cells mimicking  the tumor native 
microenvironment (Asghar et al., 2015). These strategically-designed approaches are 
increasingly used to study mechanisms of disease progression or drug effect in cancer. 
 
These approaches are now implemented with the use of numerous kinds of biomaterials 
such as hydrogels, scaffolds, and basement membrane extracts. Three-dimensional models 
based on materials with elevated mimicking of in vivo tissue properties offer researcher 
the ideal tool to improve the standard culturing systems, i) allowing cancer cells to growth 
in native microenvironmental conditions and ii) providing unique platform to study bio-
physical aspects, that cannot be included into standard monolayer or scaffold-free cultures. 
As an example, 3D scaffolds that enable the tuning of matrix microstructure, stiffness and 
composition offer an in vitro experimental model to study the effects exerted by these 
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physical and mechanical parameters on the behavior of cancer cells (Insua-Rodriguez et 
al., 2016; Levental et al., 2009 and Shawn et al., 2012).  
It is known, indeed, that a dynamic mechanical interaction subsists between cancer cells 
and the surrounding ECM environment and governs essential tumor processes (Kumar et 
al., 2009). The mechanical characteristics of tumors and tumor cells are predictive of the 
disease clinical behavior (Plodinec et al., 2012; Xu et al., 2012) and mechanical signaling 
from the ECM influence the tumor phenotypes (Paszek et al., 2005; Tan et al., 2014 and 
Ulrich et al., 2009). Thus, investigating the cancer mechanobiology represents a great 
opportunity to achieve a better understanding of the disease and to identify novel possible 
therapeutic targets or prognostic biomarkers.  
In this study we have utilized type I collagen scaffolds as an in vitro 3D biomimetic model 
to study the interaction occurring between MDA-MB-231 or MCF-7 breast cancer cells,  
known for having different clinical aggressiveness (Kolliday et al., 2011), and the 
surrounding ECM. Towards this end, our collagen scaffold seems a model of choice, as it 
(i) resembles the main component of the ECM; (ii) can be easily fabricated; (iii) and each 
feature can be tuned (e.g. structure, pore size, porosity, wettability, degradation) (Minardi 
et al., 2014).  
The pore sizes of the collagen scaffolds ranged from 150 to 300 μm, which is sufficient for 
exchange of oxygen and nutrients, and suitable for cell attachment (Chen et al., 2012). We 
first demonstrated that our collagen scaffolds retained the typical D- periodicity of native 
collagen tissues. Collagen molecules are packed in a quarter staggered fashion which gives 
rise to a repeating banding pattern, the so-called D-periodicity or D-band, of about 67nm 
(Fratzl et al., 2008). It has been found that the transverse D-banding periodic pattern is a 
key player of collagen fiber mechanical properties, while it has been correlated with 
pathological conditions and it is believed to play a significant role in cell-collagen 
interactions (Grant et al., 2012). As an example, a strong correlation between the 
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orientation of D-band and cell elongation has been reported on two-dimensional collagen 
surfaces (Poole et al., 2005).  
We next proved, in a xenograft orthotopic murine model, that the ECM characteristics of 
breast tumors are related to the phenotypes and the aggressiveness of cancer cells. We 
showed that in vivo tumors generated by MDA-MB-231 cells, belonging to the more 
aggressive basal-like subtype (corresponding to TNBC), were characterized by a distinct 
ECM signature compared to tumors generated by MCF-7. In particular, MDA-MB-231 
tumors were characterized by elevated collagen content and a high degree of collagen 
linearization. Furthermore, in tumors generated by MDA-MB-231 we found a higher 
expression of the collagen cross-linking enzyme LOX. Increased LOX levels and tumor 
stiffness have been associated with progression (Butcher et al., 2009; Levental et al., 2009; 
Oskarsson et al., 2013 and Payne et al., 2007) and local invasion via oriented cell 
migration on aligned collagen fibers (Provenzano et al., 2006). Moreover, the elevated 
expression of fibrillar collagens has been linked to the invasive and aggressive behavior of 
breast tumors (Zaman et al., 2006). Similar changes have been described by Acerbi and 
colleagues in specific subtypes of breast cancers. The authors found that the stroma at the 
invasive region of basal-like and HER2 tumor subtypes was the most heterogeneous and 
the stiffest when compared to the less aggressive luminal A and B subtypes (Acerbi et al., 
2015).  
We next investigated the phenotypes and behavior of breast cancer cells when growing in 
collagen-based 3D scaffolds. Both cell lines within the scaffolds preserved their specific 
traits. Weakly aggressive MCF-7 cells displayed an epithelial-like morphology and a high 
expression of the E-cadherin epithelial marker. Conversely, MDA-MB-231 showed an 
infiltrating and mesenchymal phenotype with lower E-cadherin expression and high levels 
of vimentin. Loss of E-cadherin is a key step in the epithelial to mesenchymal transition 
(EMT) process and has been implicated in cancer progression and metastasis
 
(Beavon et 
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al., 2000; Onder et al., 2008). On the other hand, vimentin expression fosters a number of 
cellular changes involved in the acquisition of a mesenchymal trait, including increased 
cell motility (Mendez et al., 2010). The 3D environmental conditions stimulated different 
responses between MDA-MB-231 and MCF-7. Consistently with the more aggressive 
phenotype, MDA-MB-231 cells migrated radially toward the rim of the scaffold assuming 
a migratory pattern called “Indian filing”. Conversely, this behavior was not observed for 
less invasive MCF-7 cells.  
Drug sensitivity was also affected by culturing breast cancer cells in this 3D model. In 
particular, the ER
+
 luminal A cell lines proved little responsiveness to Doxorubicin in the 
3D settings, while sensitivity resulted much higher in monolayer culture. Consistently, 
there is emerging clinical evidence that indicates possible lack of benefit from 
anthracycline chemotherapy in patient with ER
+ 
luminal A breast tumors with non 
aggressive features
 
(Kathy. et al., 2011; Barrios et al., 2009).  
 
In order to study the mechanical interaction of the breast cancer cells with the collagen 
matrix we first evaluated the compression-dependent viscoelastic properties of the 
scaffolds. To this aim we developed a low-force compression testing device: the 
instrument consisted of a cylindrical piston to indent the samples with known loadings, 
and a comparator for detecting the piston displacement to a determined load. Using this 
prototype device, we were able to show that MDA-MB-231 cancer cells, when cultured 
for 10 day on the scaffolds, produced a significant increase in the macroscopic stiffness of 
collagen samples (the average slope of the sigma-epsilon curve increased from 46.9 ± 2.7 
kPa to 57.9 ± 3.6 kPa). Conversely, MCF-7 did not affect this property.  
These data were confirmed by the use of Dynamic Mechanical Analysis, a standard 
technique for measuring the mechanical properties of biomaterials. In compression, the 
scaffolds showed three characteristic deformation stages, as it was already been describe 
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for similar collagen materials (Figure 35): the first stage was the linear elastic stage 
(dominated by the bending of pore edges), followed by a stress plateau (dominated by pore 
wall buckling) and a stage of densification (dominated by pore collapse throughout the 
scaffold) (Chen et al., 2012). The slopes of the initial linear stages on the curves represent 
the compressive modulus. 
 
 
Figure 35. Example of unidirectional compression stress-strain curves of collagen 
scaffolds determined with a DMA instrument (Chen et al., 2012). 
 
 
The differences between control scaffolds and scaffolds in contact with MDA-MB-231 
assessed by DMA were similar to those observed with the prototype low-force 
compressive device. Although the modulus values determined by the DMA analysis 
resulted markedly lower than those determined with the prototype device (1.7 ± 0.7 kPa 
versus 46.9 ± 2.7 kPa as assessed by DMA or by the low-force testing device, 
respectively), the ability of MDA-MB-231 to increase the stiffness of the scaffold was 
confirmed by both techniques.  
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We next characterized the structural remodeling induced by cancer cells on the collagen 
matrix. We showed that both cell lines induced a decrease in the scaffold swelling 
property and pore area, probably as a results of the deposition of new matrix. The decrease 
in the swelling property and pore size can lead to an increase in the stiffness of collagen 
polymers (Grover et al., 2012). Although both cell lines affected these two parameters, 
only MDA-MB-231 were able to modify the scaffold stiffness. With a deeper 
investigation, we showed that MDA-MB-231 were able to alter the scaffold architecture 
producing a more organized and packed matrix, characterized by the presence of linear 
collagen fibers. In addition, this cell line, when cultured on the scaffold, expressed high 
levels of the collagen-crosslinking enzyme LOX (consistently with what observed in vivo). 
Conversely, MCF-7 expressed lower levels of LOX and were unable to significantly 
modify the architecture of the matrix. Collagen crosslinking is related to its stiffness 
properties (Buehler et al., 2006) and is, to a large extent, enzymatically catalyzed by the 
lysyl oxidase family (Payne et al., 2007). When LOX activity was blocked, MDA-MB-231 
ability to alter the scaffold stiffness was impaired, providing a causal correlation between 
LOX-mediated collagen crosslinking and the observed stiffness increase.  
This finding has particular relevance, since increased LOX expression and tumor stiffness 
have been associated with progression (Butcher et al., 2009; Levental et al., 2009; 
Oskarsson et al., 2013) and local invasion via oriented cell migration along aligned 
collagen fibers (Egeblad et al., 2010; Provenzano et al., 2006). LOX has also been found 
associated with breast cancer prognosis. Patients with high LOX-expressing tumors have 
poor overall survival, and inhibition of LOX has been demonstrated to eliminate 
metastases in mice. Recent research has also shown that overexpression of LOX is crucial 
to promote metastasis in several cancers, including breast cancer (Erler et al., 2006; Erler 
et al., 2009 and Kirschmann et al., 2002), non-small cell lung cancer (Shi et al., 2012) and 
colorectal cancer (Baker et al. 2011). 
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MDA-MB-231 seemed also to display the ability of collagen internalization which 
constitutes an important mechanism for ECM turnover and remodeling (Curino et al., 
2005). This process has been correlated with breast cancer progression and was first 
described in tumor-associated stromal cells which are able to internalize and degrade 
collagen through the uPARAP/Endo180 receptor (Engelholm et al., 2003). Recent 
findings have shown that the collagen receptor Endo180 is also expressed in basal-like 
breast tumor cells (Wienke et al., 2007) and that some cancer cells have the ability to 
internalize collagen (Huijbers et al., 2010; Ikenaga et al. 2012). In addition, it has been 
found that EMT fosters this pathway, leading prostate cancer cells with a mesenchymal 
phenotype to develop an enhanced ability to internalize collagen (Ikenaga et al., 2012).  
 
 
Finally, we studied through Atomic Force Microscopy the mechanical micro-properties of 
single collagen fibers, comparing fibers taken from uncellularized scaffolds and fibers 
taken from scaffolds cultured with MDA-MB-231. No significant differences were 
observed between the Young’s modulus of collagen fibers from control scaffolds 
compared to fibers from scaffolds after the culture with breast cancer cells. This results is 
explained by the functional correlation found between the increase in the scaffold’s 
stiffness produced by MDA-MB-231 and the activity of LOX. It is know that the collagen 
cross-linking mediated by this enzyme involve inter-fibers bonds, as the substrate to 
generate cross-links are collagen fibrils in a quarter staggered array (Kagan and Li, 2003). 
When analyzing the mechanical properties at the single fiber level this type of interactions 
are probably lost and, thus, no differences are observed between control fibers and fibers 
in contact with cancer cells. The results obtained were consistent with other previously 
reported data on the Young’s modulus of collagen fibers determined through AFM 
(Wenger et al., 2007; Liu et al., 2013; Minardi et al., 2015).  
85 
 
Despite the fact that 3D collagen models are very promising, their characterization can be  
complicated. Unlike hard scaffolds, the mechanical properties of soft materials are 
difficult to be characterized due to their fragility. They usually can only tolerate nN 
stresses, making them difficult to measure. Although AFM is a surface characterization 
technique, it offer a significant tool for imaging and characterization of the micro-
structural and mechanical properties of these 3D materials (Stylianou, 2017 and Rettler et 
al., 2013) (Figure 36).  
 
 
 
Figure 36. AFM is suitable to investigate the properties of collagen fibers (Rettler et 
al., 2013). 
 
There are a number of studies where the coupling of an AFM characterization with the use 
of collagen materials permitted to explore macro- and micro- properties of tailored 
collagens and the effect of these properties on different cell types. For example, Tan et al. 
applied AFM imaging to investigate the surface modifications induced by the 
incorporation of chitosan on collagen 3D gels (Tan et al., 2010). Vicens-Zygmunt et al. 
used AFM to study the ribose-induced mechanical alterations and the consequent 
fibroblast phenotypes in collagen gels by assessing their Young’s elastic modulus (Vicens-
Zygmunt et al., 2015). Nam and colleagues used AFM to explore the strain stiffening of 
collagen gels (Nam et al., 2016). Zhu et al. recently reported a new approach for 
characterizing the stiffness and elastic modulus of collagen-chitosan hydrogel scaffolds 
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using AFM. They developed and introduce a mathematical model to determine the 
stiffness and the elastic modulus of a scaffold from its force curve obtained in liquid 
conditions and using a triangle probe to indent the samples (Figure 37) (Zhu et al., 2011).  
 
 
 
Figure 37. Schematic of indentation of a thin biological sample by a triangle probe in 
AFM, developed by Zhu et al. 
 
Using this method, Zhu and colleagues were able to demonstrate that fibroblast-like cells 
are able to significantly increase the elastic modulus of collagen fibers. Furthermore, this 
method allowed the authors to efficiently determine the elastic moduli of mouse pancreas 
and heart samples.  
Finally, van Helvert and Friedl performed AFM nanoindentation in live-cell culture in 
order to directly address local elasticity changes generated by moving cells on fibrillar 
type I collagen gels (van Helvert and Friedl, 2016).  
Thus, coupling the AFM technique with the use of in vitro scaffold- or gel- based models 
offer a unique opportunity to collect qualitative or quantitative information on: i) micro-
properties of soft tissue materials with diverse structure and composition; ii) forces at the 
single cell level; iii) matrix-cells micro-interactions.  
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In conclusion we provided evidence that cancer cells belonging to the aggressive basal-
like subtype of breast tumors display the ability to modify the surrounding ECM and, in 
particular, are able to alter the mechanical properties of extracellular collagen. This 
process is caused by a remodeling on the matrix architecture mediated by the activity of 
LOX, a collagen cross-linking enzyme, highly expressed by the invasive breast cancer cell 
line.  
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7. Conclusions and future perspectives 
 
Overall this work provides evidence that aggressive basal-like breast cancer cells modify 
the surrounding ECM and, in particular, are able to alter the architecture of extracellular 
collagen and increase its stiffness.  
These findings were obtained by coupling an experimental in vitro cell culture model, 
based on 3D collagen scaffolds, with a number of different methodologies to characterize 
the composition and the structural and mechanical macro- and micro- properties of soft 
biomaterials. The remodeling produced in the collagen scaffolds by aggressive cancer 
cells is consistent with the characteristics observed in the ECM of in vivo tumors and with 
previous findings on the ECM properties of basal-like breast cancers
 
(i.e. Acerbi et al., 
2015). These observations confirm that our model might constitute a relevant and 
informative experimental system to further address the mechanobiology of cell-ECM 
interaction.  
In particular, one of the future application of this model will be the study of the 
influence of scaffold stiffness on the phenotype and behavior of cancer cells. The scaffold 
stiffness will be modified by increasing the concentration of the crosslinking reagent 
during the chemical synthesis of the samples. The cross-link conditions will be then 
correlated with the compressive modulus assessed with the prototype device, and the 
impact of these properties on the cellular and molecular phenotypes of cancer cells, as well 
as on their drug sensitiveness, will be evaluated.  
The use of collagen as the main component of our scaffold will allow for the 
evolvement of our system into progressively complex models as: (i) it is the main 
component of the ECM of every tissue of the body; (ii) its abundance of functional groups 
(carboxylic and aminic groups), will enable for the introduction of other components of 
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the ECM (e.g. proteins, carbohydrates), bioactive factors and stromal cells into the system 
to engineer more sophisticated tissue-specific tumor niches; (iii) the possibility to create 
complex geometries and intra-scaffold compartments, to mimic complex tissues
 
(Minardi 
et al., 2014); (iv) the changes in its concentration, type and crosslinking can lead to large 
effects on the mechanical properties of the tissue.  
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